Liqiong Cai

1.7k total citations
30 papers, 735 citations indexed

About

Liqiong Cai is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Liqiong Cai has authored 30 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Liqiong Cai's work include Cancer-related molecular mechanisms research (5 papers), Lymphatic System and Diseases (4 papers) and MicroRNA in disease regulation (4 papers). Liqiong Cai is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Lymphatic System and Diseases (4 papers) and MicroRNA in disease regulation (4 papers). Liqiong Cai collaborates with scholars based in China and United States. Liqiong Cai's co-authors include Zehua Wang, Hongbo Wang, Ping Yin, Min Xu, Jing Cai, Yu Hu, Lili Luo, Juntao Luo, Gaofei Xu and Fen Zhou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Scientific Reports.

In The Last Decade

Liqiong Cai

25 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liqiong Cai China 11 275 253 189 139 117 30 735
Yongrong Lai China 19 134 0.5× 239 0.9× 240 1.3× 116 0.8× 25 0.2× 69 1.3k
Hristos Z. Kaimakliotis United States 20 133 0.5× 229 0.9× 246 1.3× 18 0.1× 33 0.3× 89 1.3k
Soon Man Yoon South Korea 22 95 0.3× 193 0.8× 469 2.5× 32 0.2× 63 0.5× 85 1.4k
Chi‐Long Chen Taiwan 20 118 0.4× 246 1.0× 262 1.4× 18 0.1× 19 0.2× 49 947
Maanit Shapira Israel 13 125 0.5× 409 1.6× 313 1.7× 23 0.2× 16 0.1× 22 768
Qing Wei China 14 50 0.2× 154 0.6× 247 1.3× 60 0.4× 15 0.1× 50 754
Julianne D. Twomey United States 10 51 0.2× 302 1.2× 504 2.7× 37 0.3× 43 0.4× 18 988
Xiaojiao Zeng China 10 77 0.3× 141 0.6× 110 0.6× 26 0.2× 19 0.2× 20 395
Mehdi Karimi‐Shahri Iran 13 49 0.2× 152 0.6× 130 0.7× 22 0.2× 84 0.7× 27 502

Countries citing papers authored by Liqiong Cai

Since Specialization
Citations

This map shows the geographic impact of Liqiong Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqiong Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqiong Cai more than expected).

Fields of papers citing papers by Liqiong Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liqiong Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqiong Cai. The network helps show where Liqiong Cai may publish in the future.

Co-authorship network of co-authors of Liqiong Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Liqiong Cai. A scholar is included among the top collaborators of Liqiong Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liqiong Cai. Liqiong Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ji, Lin Xiang, Liqiong Cai, et al.. (2025). Vimentin Fragmentation and Its Role in Amyloid-Beta Plaque Deposition in Alzheimer’s Disease. International Journal of Molecular Sciences. 26(7). 2857–2857.
2.
Li, Guoqing, Xiaoling Zhou, Wenhan Li, et al.. (2025). Extracellular vesicles from ovarian cancer cells induce senescent lipid-laden macrophages to facilitate omental metastasis. Journal of Nanobiotechnology. 23(1). 540–540.
3.
Chen, Lulu, et al.. (2025). Spatiotemporal dynamics of ecological quality and its drivers in Shanxi Province and its planned mining areas. Scientific Reports. 15(1). 31023–31023. 1 indexed citations
5.
Wang, Fei, Yingying Li, Jui‐Hung Weng, et al.. (2025). Utilization of artificial circular RNAs as miRNA sponges and anti-PD-1 scFv expression platforms to suppress hepatocellular carcinoma progression. Frontiers in Immunology. 16. 1609165–1609165. 2 indexed citations
6.
Liu, Pan, Lisha Xie, Lin Huang, et al.. (2024). TIE1 promotes cervical cancer progression via Basigin-matrix metalloproteinase axis. International Journal of Biological Sciences. 20(6). 2297–2309. 1 indexed citations
8.
Liu, Ting, Jian Cai, Jing Cai, Zehua Wang, & Liqiong Cai. (2021). EZH2-miRNA Positive Feedback Promotes Tumor Growth in Ovarian Cancer. Frontiers in Oncology. 10. 608393–608393. 12 indexed citations
9.
Cai, Liqiong, et al.. (2021). GADD45B Facilitates Metastasis of Ovarian Cancer Through Epithelial–Mesenchymal Transition. OncoTargets and Therapy. Volume 14. 255–269. 11 indexed citations
10.
Cai, Liqiong, et al.. (2020). Long noncoding RNA AFAP1-AS1 promoted osteosarcoma proliferation and invasion via upregulating BDNF. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Liao, Danying, Fen Zhou, Lili Luo, et al.. (2020). Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. The Lancet Haematology. 7(9). e671–e678. 328 indexed citations
13.
Cai, Liqiong, et al.. (2016). [The social marketing models and policy advices for HIV rapid testing initiated by non-govermental organization].. PubMed. 50(10). 846–849. 2 indexed citations
14.
Teng, Hua, Xiaoyan Xin, Liqiong Cai, et al.. (2016). S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation. Oncology Reports. 35(6). 3419–3426. 13 indexed citations
15.
Cai, Liqiong, Zehua Wang, & Denghua Liu. (2015). Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression. Tumor Biology. 37(5). 6359–6369. 24 indexed citations
16.
Cai, Liqiong, Gaofei Xu, Changying Shi, et al.. (2014). Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment. Biomaterials. 37. 456–468. 129 indexed citations
17.
Cai, Liqiong, et al.. (2014). The relationship between gene expression of Forkhead box C2 and tumor progression in cervical carcinoma.. PubMed. 35(6). 625–30. 3 indexed citations
18.
Cai, Liqiong, et al.. (2009). Role of tumor‐associated lymphatic endothelial cells in metastasis: A study of epithelial ovarian tumor in vitro. Cancer Science. 101(3). 679–685. 7 indexed citations
20.
Lu, Shi, Xiaoyi Wang, Liqiong Cai, et al.. (2007). Gene therapy for ovarian cancer using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene directed by MDR1 promoter. Cancer Biology & Therapy. 6(3). 397–404. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026